An internationally recognized expert in the tear film, Donald R. Korb, OD, is often described as one of the field's great clinician-scientists. His accomplishments include the development of the first thin membrane hydrogellens, the forerunner of contemporary soft lenses. He was also the first to describe a number of significant clinical entities, including giant papillary conjunctivitis, meibomian gland obstruction, and lid wiper epitheliopathy. He has founded several research and development companies, including Ocular Research of Boston, which developed Soothe®XP, a lipidbased treatment for dry eye. Dr. Korb takes special pride in having been a Regent's Lecturer at the University of California, Berkeley.